Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

Nature Genetics

Volumn 45, Issue 10, 2013, Pages 1221-1225

  Chubb, Daniel ^a   Weinhold, Niels ^b   Broderick, Peter ^a   Chen, Bowang ^c   Johnson, David C ^a   Försti, Asta ^c,d   Vijayakrishnan, Jayaram ^a   Migliorini, Gabriele ^a   Dobbins, Sara E ^a   Holroyd, Amy ^a   Hose, Dirk ^b,e   Walker, Brian A ^a   Davies, Faith E ^a   Gregory, Walter A ^f   Jackson, Graham H ^g   Irving, Julie A ^h   Pratt, Guy ⁱ   Fegan, Chris ^j   Fenton, James A L ^k   Neben, Kai ^b   Hoffmann, Per ^l   Nöthen, Markus M ^l,m   Mühleisen, Thomas W ^l   Eisele, Lewin ⁿ   Ross, Fiona M ^o   Straka, Christian ^p   Einsele, Hermann ^q   Langer, Christian ^r   Dörner, Elisabeth ^b   Allan, James M ^h   Jauch, Anna ^b   Morgan, Gareth J ^a   Hemminki, Kari ^b   Houlston, Richard S ^a   Goldschmidt, Hartmut ^b,e   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d LUND UNIVERSITY   (Sweden)

^e National Centre of Tumour Diseases   (Germany)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g ROYAL VICTORIA INFIRMARY   (United Kingdom)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^j CARDIFF UNIVERSITY   (United Kingdom)

^k LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^l UNIVERSITY OF BONN   (Germany)

^m GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

ⁿ UNIVERSITY HOSPITAL ESSEN   (Germany)

^o Wessex Regional Cytogenetic Laboratory   (United Kingdom)

^p Abteilung Hämatologie und Onkologie   (Germany)

^q UNIVERSITY OF WÜRZBURG   (Germany)

^r UNIVERSITY OF ULM   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA DRB5 ANTIGEN; MESSENGER RNA; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ARTICLE; CHROMOSOME 22Q; ENHANCER REGION; FOLLOW UP; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LYMPHOCYTE PROLIFERATION; MULTIPLE MYELOMA; PRIORITY JOURNAL; STEADY STATE;

CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MULTIPLE MYELOMA;

EID: 84885022887     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2733     Document Type: Article

References (49)

1. Kyle, R.A. & Rajkumar, S.V. Multiple myeloma. N. Engl. J. Med. 351, 1860-1873 (2004).
2. Palumbo, A. & Anderson, K. Multiple myeloma. N. Engl. J. Med. 364, 1046-1060 (2011).
3. Broderick, P., et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat. Genet. 44, 58-61 (2012).
4. Weinhold, N., et al. The CCND1 G870A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat. Genet. 45, 522-525 (2013).
5. Schmermund, A., et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-Aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle. Am. Heart J. 144, 212-218 (2002).
6. Morgan, G.J., et al. First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. Lancet 376, 1989-1999 (2010).
7. Power, C. & Elliott, J. Cohort profile: 1958 British birth cohort (National Child Development Study). Int. J. Epidemiol. 35, 34-41 (2006).
8. Clayton, D.G., et al. Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat. Genet. 37, 1243-1246 (2005).
9. Price, A.L., et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
10. Pettiti, D. Meta-Analysis decision analysis and cost-effectivness analysis. Oxford University Press (1994).
11. Houlston, R.S., et al. Meta-Analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat. Genet. 42, 973-977 (2010).
12. Jones, A.M., et al. TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut 61, 248-254 (2012).
13. Skibola, C.F., et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat. Genet. 41, 873-875 (2009).
14. Conde, L., et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat. Genet. 42, 661-664 (2010).
15. Smedby, K.E., et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet. 7, e1001378 (2011).
16. Enciso-Mora, V., et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat. Genet. 42, 1126-1130 (2010).
17. Leslie, S., Donnelly, P. & McVean, G. A statistical method for predicting classical HLA alleles from SNP data. Am. J. Hum. Genet. 82, 48-56 (2008).
18. Dilthey, A.T., Moutsianas, L., Leslie, S. & McVean, G. HLA IMP-An integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 27, 968-972 (2011).
19. Gross, J.A., et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity 15, 289-302 (2001).
20. Liao, M., et al. Genome-wide association study identifies common variants at TNFRSF13B associated with IgG level in a healthy Chinese male population. Genes Immun. 13, 509-513 (2012).
21. Seshasayee, D., et al. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18, 279-288 (2003).
22. Moreaux, J., et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106, 1021-1030 (2005).
23. Yaccoby, S., et al. Atacicept (TACI-Ig) inhibits growth of TACIhigh primary myeloma cells in SCID-hu mice and in coculture with osteoclasts. Leukemia 22, 406-413 (2008).
24. Gil, J., Bernard, D. & Peters, G. Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol. 24, 117-125 (2005).
25. Aguilo, F., Zhou, M.M. & Walsh, M.J. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 71, 5365-5369 (2011).
26. Scott, C.L., et al. Role of the chromobox protein CBX7 in lymphomagenesis. Proc. Natl. Acad. Sci. USA 104, 5389-5394 (2007).
27. Walker, B.A., et al. Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood 108, 1733-1743 (2006).
28. Nica, A.C., et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 7, e1002003 (2011).
29. Stranger, B.E., et al. Patterns of cis regulatory variation in diverse human populations. PLoS Genet. 8, e1002639 (2012).
30. Dimas, A.S., et al. Common regulatory variation impacts gene expression in a cell type dependent manner. Science 325, 1246-1250 (2009).
31. Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 28, 817-825 (2010).
32. Dewald, G.W., Kyle, R.A., Hicks, G.A. & Greipp, P.R. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66, 380-390 (1985).
33. Debes-Marun, C.S., et al. Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia 17, 427-436 (2003).
34. Fonseca, R., et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia 23, 2210-2221 (2009).
35. Walker, B.A., et al. A compendium of myeloma-Associated chromosomal copy number abnormalities and their prognostic value. Blood 116, e56-e65 (2010).
36. Eisen, T., Matakidou, A. & Houlston, R. Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS). BMC Cancer 8, 244 (2008).
37. Penegar, S., et al. National study of colorectal cancer genetics. Br. J. Cancer 97, 1305-1309 (2007).
38. Purcell, S., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
39. Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-Analysis. Stat. Med. 21, 1539-1558 (2002).
40. Ioannidis, J.P., Ntzani, E.E. & Trikalinos, T.A. 'Racial' differences in genetic effects for complex diseases. Nat. Genet. 36, 1312-1318 (2004).
41. Willer, C.J., Li, Y. & Abecasis, G.R. METAL: fast and efficient meta-Analysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
42. Altieri, A., Chen, B., Bermejo, J.L., Castro, F. & Hemminki, K. Familial risks and temporal incidence trends of multiple myeloma. Eur. J. Cancer 42, 1661-1670 (2006).
43. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007).
44. Myers, S., Bottolo, L., Freeman, C., McVean, G. & Donnelly, P. A fine-scale map of recombination rates and hotspots across the human genome. Science 310, 321-324 (2005).
45. Gabriel, S.B., et al. The structure of haplotype blocks in the human genome. Science 296, 2225-2229 (2002).
46. Chiecchio, L., et al. Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma. Leukemia 20, 1610-1617 (2006).
47. Neben, K., et al. Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation. Haematologica 95, 1150-1157 (2010).
48. Stranger, B.E., et al. Genome-wide associations of gene expression variation in humans. PLoS Genet. 1, e78 (2005).
49. Stranger, B.E., et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315, 848-853 (2007).